Results 21 to 30 of about 4,692,840 (382)

Risk factors for multidrug-resistant tuberculosis in the Central African Republic: A case-control study

open access: yesJournal of Infection and Public Health, 2023
Background: The emergence and spread of multidrug-resistant tuberculosis (MDR-TB) presents a challenge to the ''End TB by 2035'' strategy. This study aimed to identify the risk factors associated with MDR-TB in patients admitted to the pneumo-physiology ...
Jean de Dieu Longo   +6 more
doaj  

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda

open access: yesHuman Resources for Health, 2009
Background To increase access to antiretroviral therapy in resource-limited settings, several experts recommend "task shifting" from doctors to clinical officers, nurses and midwives.
Namagala Elizabeth   +10 more
doaj   +1 more source

Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. [PDF]

open access: yes, 2007
OBJECTIVE: Increasing access to highly active antiretroviral therapy to reach all those in need in developing countries (scale up) is slowly expanding to HIV-positive children, but documented experience remains limited. We aimed to describe the clinical,
Akao, K   +9 more
core   +2 more sources

Antiretroviral Side Effects on Adherence in People Living with HIV/AIDS

open access: yesNurse Media: Journal of Nursing, 2018
Background: Antiretroviral therapy is a lifelong treatment in people living with HIV/AIDS (PLWHA). Adherence is the key to the effectiveness of antiretroviral therapy.
Gede Arya Bagus Arisudhana   +2 more
doaj   +1 more source

Development and validation of a composite programmatic assessment tool for HIV therapy. [PDF]

open access: yesPLoS ONE, 2012
We developed and validated a new and simple metric, the Programmatic Compliance Score (PCS), based on the IAS-USA antiretroviral therapy management guidelines for HIV-infected adults, as a predictor of all-cause mortality, at a program-wide level.
Viviane D Lima   +7 more
doaj   +1 more source

Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy

open access: yesJournal of Clinical Investigation, 2019
Chromosomal integration of genome-intact HIV-1 sequences into the host genome creates a reservoir of virally infected cells that persists throughout life, necessitating indefinite antiretroviral suppression therapy.
Kevin B. Einkauf   +14 more
semanticscholar   +1 more source

Factors influencing the retention of clients in oral pre-exposure prophylaxis (PrEP) care at 3 months after initiation in the Omusati region of Namibia

open access: yesInternational Journal of Africa Nursing Sciences, 2023
Background: The United Nations has set a target of ending the HIV/AIDS epidemic as a public health threat by 2030. The WHO recommended the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention for all people at substantial risk of HIV infection ...
Trevor Dzenga   +4 more
doaj  

A case report of clinical implications of a delayed antiretroviral therapy switch in a patient with multiple treatment interruptions

open access: yesSAGE Open Medical Case Reports, 2022
The Namibia national antiretroviral therapy guidelines recommend that patients living with HIV who interrupt antiretrovirals and in the process disengage from care be restarted on their usual antiretroviral therapy regimen upon return.
Mireille A Mpalang Kakubu   +3 more
doaj   +1 more source

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda [PDF]

open access: yes, 2011
Little is known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan ...
Bakanda, Celestin   +8 more
core   +2 more sources

Initiation of antiretroviral therapy

open access: yesIndian Journal of Sexually Transmitted Diseases and AIDS, 2014
With the widespread availability of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Further, the current antiretroviral drug combinations are safer and the availability of newer monitoring assays and guidelines has vastly improved the patient management.
Pallavi Ailawadi, Deepika Pandhi
openaire   +4 more sources

Home - About - Disclaimer - Privacy